Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9484 | 1151 | 26.4 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
156 | 3 | MYCOSES//MYCOLOGY//CANDIDA ALBICANS | 62026 |
55 | 2 | CANDIDA ALBICANS//CANDIDA//ASPERGILLOSIS | 29629 |
9484 | 1 | FLUCONAZOLE//MICRODILUTION TEST//SUSCEPTIBILITY TESTING | 1151 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FLUCONAZOLE | authKW | 707127 | 18% | 13% | 202 |
2 | MICRODILUTION TEST | authKW | 132639 | 0% | 100% | 5 |
3 | SUSCEPTIBILITY TESTING | authKW | 125934 | 4% | 10% | 48 |
4 | FOSFLUCONAZOLE | authKW | 110531 | 0% | 83% | 5 |
5 | OROPHARYNGEAL CANDIDIASIS | authKW | 104455 | 1% | 25% | 16 |
6 | CLIN PHARMACOLSHIBUYA KU | address | 84887 | 0% | 80% | 4 |
7 | D0870 | authKW | 82896 | 0% | 63% | 5 |
8 | MICRODILUTION | authKW | 74585 | 1% | 19% | 15 |
9 | CAS 86386 73 4 | authKW | 70738 | 0% | 67% | 4 |
10 | ANTIFUNGAL SUSCEPTIBILITY TESTING | authKW | 63472 | 1% | 16% | 15 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Mycology | 12910 | 14% | 0% | 157 |
2 | Microbiology | 12180 | 43% | 0% | 495 |
3 | Infectious Diseases | 8685 | 26% | 0% | 301 |
4 | Pharmacology & Pharmacy | 4274 | 36% | 0% | 419 |
5 | Dermatology | 1217 | 8% | 0% | 95 |
6 | Immunology | 389 | 11% | 0% | 121 |
7 | Medicine, General & Internal | 54 | 5% | 0% | 57 |
8 | Medical Laboratory Technology | 53 | 1% | 0% | 16 |
9 | Tropical Medicine | 35 | 1% | 0% | 12 |
10 | Virology | 28 | 2% | 0% | 20 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLIN PHARMACOLSHIBUYA KU | 84887 | 0% | 80% | 4 |
2 | ALLERGY OUTPATIENT INFECT DIS INTERNAL | 26528 | 0% | 100% | 1 |
3 | CARIESIUS ANALYT UNIT | 26528 | 0% | 100% | 1 |
4 | CLIN MICROBIOL MYCOL REFERENCE | 26528 | 0% | 100% | 1 |
5 | COMM CLIN STAND 2000 | 26528 | 0% | 100% | 1 |
6 | DEAN RYLE ST HORSEFERRY RD | 26528 | 0% | 100% | 1 |
7 | DENT SPECIAL PATIENTS SECT | 26528 | 0% | 100% | 1 |
8 | ECOL EVOLUT CONSERVAT CEEC | 26528 | 0% | 100% | 1 |
9 | EQUIPE 4 INSERM U314 | 26528 | 0% | 100% | 1 |
10 | G GROOTEPLEIN ZUID 24 | 26528 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MYCOSES | 48603 | 6% | 2% | 74 |
2 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 22912 | 12% | 1% | 143 |
3 | JOURNAL DE MYCOLOGIE MEDICALE | 20468 | 2% | 3% | 26 |
4 | JOURNAL OF CLINICAL MICROBIOLOGY | 10778 | 9% | 0% | 104 |
5 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 9192 | 6% | 1% | 66 |
6 | JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY | 8004 | 1% | 2% | 15 |
7 | CHEMOTHERAPY | 4155 | 2% | 1% | 20 |
8 | CLINICAL INFECTIOUS DISEASES | 3767 | 4% | 0% | 43 |
9 | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 3333 | 2% | 0% | 26 |
10 | MYCOPATHOLOGIA | 3239 | 2% | 1% | 21 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FLUCONAZOLE | 707127 | 18% | 13% | 202 | Search FLUCONAZOLE | Search FLUCONAZOLE |
2 | MICRODILUTION TEST | 132639 | 0% | 100% | 5 | Search MICRODILUTION+TEST | Search MICRODILUTION+TEST |
3 | SUSCEPTIBILITY TESTING | 125934 | 4% | 10% | 48 | Search SUSCEPTIBILITY+TESTING | Search SUSCEPTIBILITY+TESTING |
4 | FOSFLUCONAZOLE | 110531 | 0% | 83% | 5 | Search FOSFLUCONAZOLE | Search FOSFLUCONAZOLE |
5 | OROPHARYNGEAL CANDIDIASIS | 104455 | 1% | 25% | 16 | Search OROPHARYNGEAL+CANDIDIASIS | Search OROPHARYNGEAL+CANDIDIASIS |
6 | D0870 | 82896 | 0% | 63% | 5 | Search D0870 | Search D0870 |
7 | MICRODILUTION | 74585 | 1% | 19% | 15 | Search MICRODILUTION | Search MICRODILUTION |
8 | CAS 86386 73 4 | 70738 | 0% | 67% | 4 | Search CAS+86386+73+4 | Search CAS+86386+73+4 |
9 | ANTIFUNGAL SUSCEPTIBILITY TESTING | 63472 | 1% | 16% | 15 | Search ANTIFUNGAL+SUSCEPTIBILITY+TESTING | Search ANTIFUNGAL+SUSCEPTIBILITY+TESTING |
10 | RENAL DRUG ELIMINATION | 59686 | 0% | 75% | 3 | Search RENAL+DRUG+ELIMINATION | Search RENAL+DRUG+ELIMINATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | REX, JH , PFALLER, MA , WALSH, TJ , CHATURVEDI, V , ESPINEL-INGROFF, A , GHANNOUM, MA , GOSEY, LL , ODDS, FC , RINALDI, MG , SHEEHAN, DJ , ET AL (2001) ANTIFUNGAL SUSCEPTIBILITY TESTING: PRACTICAL ASPECTS AND CURRENT CHALLENGES.CLINICAL MICROBIOLOGY REVIEWS. VOL. 14. ISSUE 4. P. 643 -658 | 100 | 50% | 220 |
2 | HOFFMAN, HL , PFALLER, MA , (2001) IN VITRO ANTIFUNGAL SUSCEPTIBILITY TESTING.PHARMACOTHERAPY. VOL. 21. ISSUE 8. P. 111S-123S | 70 | 69% | 10 |
3 | DENNING, DW , BAILY, GG , HOOD, SV , (1997) AZOLE RESISTANCE IN CANDIDA.EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. VOL. 16. ISSUE 4. P. 261-280 | 79 | 61% | 46 |
4 | GHANNOUM, MA , REX, JH , GALGIANI, JN , (1996) SUSCEPTIBILITY TESTING OF FUNGI: CURRENT STATUS OF CORRELATION OF IN VITRO DATA WITH CLINICAL OUTCOME.JOURNAL OF CLINICAL MICROBIOLOGY. VOL. 34. ISSUE 3. P. 489-495 | 53 | 83% | 131 |
5 | LORTHOLARY, O , PETRIKKOS, G , AKOVA, M , ARENDRUP, MC , ARIKAN-AKDAGLI, S , BASSETTI, M , BILLE, J , CALANDRA, T , CASTAGNOLA, E , CORNELY, OA , ET AL (2012) ESCMID* GUIDELINE FOR THE DIAGNOSIS AND MANAGEMENT OF CANDIDA DISEASES 2012: PATIENTS WITH HIV INFECTION OR AIDS.CLINICAL MICROBIOLOGY AND INFECTION. VOL. 18. ISSUE . P. 68 -77 | 47 | 61% | 17 |
6 | PFALLER, MA , REX, JH , RINALDI, MG , (1997) ANTIFUNGAL SUSCEPTIBILITY TESTING: TECHNICAL ADVANCES AND POTENTIAL CLINICAL APPLICATIONS.CLINICAL INFECTIOUS DISEASES. VOL. 24. ISSUE 5. P. 776 -784 | 49 | 83% | 63 |
7 | REX, JH , PFALLER, MA , GALGIANI, JN , BARTLETT, MS , ESPINELINGROFF, A , GHANNOUM, MA , LANCASTER, M , ODDS, FC , RINALDI, MG , WALSH, TJ , ET AL (1997) DEVELOPMENT OF INTERPRETIVE BREAKPOINTS FOR ANTIFUNGAL SUSCEPTIBILITY TESTING: CONCEPTUAL FRAMEWORK AND ANALYSIS OF IN VITRO IN VIVO CORRELATION DATA FOR FLUCONAZOLE, ITRACONAZOLE, AND CANDIDA INFECTIONS.CLINICAL INFECTIOUS DISEASES. VOL. 24. ISSUE 2. P. 235-247 | 48 | 52% | 515 |
8 | DAROUICHE, RO , (1998) OROPHARYNGEAL AND ESOPHAGEAL CANDIDIASIS IN IMMUNOCOMPROMISED PATIENTS: TREATMENT ISSUES.CLINICAL INFECTIOUS DISEASES. VOL. 26. ISSUE 2. P. 259 -272 | 51 | 73% | 60 |
9 | CORMICAN, MG , PFALLER, MA , (1996) STANDARDIZATION OF ANTIFUNGAL SUSCEPTIBILITY TESTING.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 38. ISSUE 4. P. 561-578 | 51 | 78% | 36 |
10 | PFALLER, MA , YU, WL , (2001) ANTIFUNGAL SUSCEPTIBILITY TESTING - NEW TECHNOLOGY AND CLINICAL APPLICATIONS.INFECTIOUS DISEASE CLINICS OF NORTH AMERICA. VOL. 15. ISSUE 4. P. 1227 -+ | 65 | 48% | 29 |
Classes with closest relation at Level 1 |